Moderna (MRNA) Current Deferred Revenue (2017 - 2026)
Moderna (MRNA) reported Current Deferred Revenue of $295 million for Q2 2026, up 35.3% from $218 million a year earlier and up 189.2% from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna posted Current Deferred Revenue of $99 million, down 35.3% from FY2024.
- Current Deferred Revenue has declined for four consecutive years, with a five-year compound annual growth rate of -52.0% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $153 million in FY2024 (-73.1%), $568 million in FY2023 (-72.1%), $2.04 billion in FY2022 (-67.4%) and $6.25 billion in FY2021 (+61.7%).
- The Q2 2026 figure ranks as the highest quarterly Current Deferred Revenue since Q3 2024.
- Year over year, Current Deferred Revenue gained in 1 of the last eight quarters, with an average decline of 45.9%.
- The high point for year-over-year Current Deferred Revenue in five years was Q3 2021 (growth of 546.2%); the low point was Q1 2023 (a decline of 78.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $102 million (Q1 2026), $99 million (Q4 2025) and $163 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 295.00 Mn |
| Mar 31, 2026 | 102.00 Mn |
| Dec 31, 2025 | 99.00 Mn |
| Sep 30, 2025 | 163.00 Mn |
| Jun 30, 2025 | 218.00 Mn |
| Mar 31, 2025 | 125.00 Mn |
| Dec 31, 2024 | 153.00 Mn |
| Sep 30, 2024 | 379.00 Mn |
| Jun 30, 2024 | 702.00 Mn |
| Mar 31, 2024 | 559.00 Mn |
| Dec 31, 2023 | 568.00 Mn |
| Sep 30, 2023 | 1.37 Bn |
| Jun 30, 2023 | 1.04 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 2.04 Bn |
| Sep 30, 2022 | 4.00 Bn |
| Jun 30, 2022 | 4.09 Bn |
| Mar 31, 2022 | 5.60 Bn |
| Dec 31, 2021 | 6.25 Bn |
| Sep 30, 2021 | 7.98 Bn |
API Access
Moderna Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();